XTL Biopharmaceuticals Lt... (XTLB)
NASDAQ: XTLB
· Real-Time Price · USD
1.33
-0.09 (-6.34%)
At close: Aug 15, 2025, 1:40 PM
1.41
6.02%
After-hours: Aug 15, 2025, 04:00 PM EDT
XTL Biopharmaceuticals Fail-to-Deliver
Total FTD Shares
5.8K
Below Average
FTD / Avg. Volume
15.51%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 11, 2025,
XTL Biopharmaceuticals Ltd. has
5,796
shares failed to deliver, representing 15.51%
of the average daily volume of
37,367
shares. Over the past year, the monthly average FTD is
7,256
shares, with the current level 20% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 11, 2025 | 1.51 | 5.8K | +488.43% |
Jun 30, 2025 | 1.14 | 985 | +885.00% |
May 30, 2025 | 1.2 | 100 | +566.67% |
Apr 14, 2025 | 1.1 | 15 | -83.87% |
Mar 28, 2025 | 1.27 | 93 | -64.37% |
Feb 27, 2025 | 1.38 | 261 | -27.30% |
Jan 29, 2025 | 1.62 | 359 | -89.43% |
Dec 31, 2024 | 2.03 | 3.4K | +2008.70% |
Nov 27, 2024 | 1.85 | 161 | -99.91% |
Oct 31, 2024 | 2.24 | 169.6K | +37421.46% |
Sep 30, 2024 | 2.4 | 452 | -23.91% |
Aug 22, 2024 | 2.75 | 594 | -12.13% |
Jul 29, 2024 | 2.97 | 676 | -78.61% |
Jun 20, 2024 | 2.29 | 3.16K | +500.76% |
May 31, 2024 | 2.64 | 526 | +762.30% |
Apr 30, 2024 | 2.59 | 61 | -99.85% |
Mar 28, 2024 | 2.81 | 40.31K | +183140.91% |
Feb 08, 2024 | 0.87 | 22 | -12.00% |
Jan 31, 2024 | 0.88 | 25 | +733.33% |
Dec 26, 2023 | 0.905 | 3 | -83.33% |
Nov 30, 2023 | 1.05 | 18 | +80.00% |
Oct 31, 2023 | 0.83 | 10 | -97.58% |
Sep 07, 2023 | 0.99 | 414 | -41.11% |
Aug 07, 2023 | 0.8 | 703 | +998.44% |
Jul 21, 2023 | 0.94 | 64 | -92.00% |
Jun 30, 2023 | 1 | 800 | +48.98% |
May 26, 2023 | 1.2 | 537 | +1242.50% |
Apr 20, 2023 | 1.27 | 40 | -63.30% |
Mar 31, 2023 | 1.31 | 109 | -72.54% |
Feb 02, 2023 | 1.35 | 397 | +21.78% |
Jan 23, 2023 | 1.36 | 326 | n/a |